Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: February 4, 2023

Patent: 10,105,415

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 10,105,415
Title:Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
Abstract: The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and fosfomycin for the treatment, prevention or alleviation of an inflammatory bowel disease such as Crohn\'s disease, ulcerative colitis or necrotizing enterocolitis of newborn and premature infants by administration of the compositions into the intestinal lumen.
Inventor(s): Heslet; Lars (Gentofte, DK), Uttenthal; Lars Otto (Salamanca, ES)
Assignee: Reponex Pharmaceuticals A/S (Horsholm, DK)
Application Number:15/328,426
Patent Claims:see list of patent claims

Details for Patent 10,105,415

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bayer Healthcare Pharmaceuticals Inc. TRASYLOL aprotinin Injection 020304 12/29/1993 See Plans and Pricing 2034-07-24
Partner Therapeutics, Inc. LEUKINE sargramostim For Injection 103362 03/05/1991 See Plans and Pricing 2034-07-24
Partner Therapeutics, Inc. LEUKINE sargramostim Injection 103362 03/05/1991 See Plans and Pricing 2034-07-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.